Orthofix Medical Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Orthofix Medical is forecast to grow earnings and revenue by 59.2% and 6.2% per annum respectively while EPS is expected to grow by 60.6% per annum.
Wichtige Informationen
59.2%
Wachstumsrate der Gewinne
60.6%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 17.4% |
| Wachstumsrate der Einnahmen | 6.2% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 14 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 902 | -22 | N/A | 114 | 4 |
| 12/31/2025 | 847 | -37 | N/A | 81 | 5 |
| 12/31/2024 | 797 | -83 | N/A | 14 | 5 |
| 6/30/2024 | 772 | -120 | -74 | -16 | N/A |
| 3/31/2024 | 760 | -126 | -91 | -30 | N/A |
| 12/31/2023 | 747 | -151 | -108 | -46 | N/A |
| 9/30/2023 | 668 | -136 | -90 | -37 | N/A |
| 6/30/2023 | 598 | -118 | -75 | -38 | N/A |
| 3/31/2023 | 529 | -76 | -67 | -38 | N/A |
| 12/31/2022 | 461 | -20 | -35 | -12 | N/A |
| 9/30/2022 | 464 | -45 | -27 | -2 | N/A |
| 6/30/2022 | 462 | -37 | -17 | 6 | N/A |
| 3/31/2022 | 465 | -37 | -13 | 8 | N/A |
| 12/31/2021 | 464 | -38 | -1 | 18 | N/A |
| 9/30/2021 | 457 | -15 | 12 | 29 | N/A |
| 6/30/2021 | 456 | -8 | 21 | 44 | N/A |
| 3/31/2021 | 407 | -29 | 41 | 64 | N/A |
| 12/31/2020 | 407 | 3 | 50 | 74 | N/A |
| 9/30/2020 | 410 | 24 | 42 | 64 | N/A |
| 6/30/2020 | 413 | -22 | 37 | 54 | N/A |
| 3/31/2020 | 456 | -4 | 28 | 46 | N/A |
| 12/31/2019 | 460 | -28 | 9 | 32 | N/A |
| 9/30/2019 | 460 | -31 | 15 | 41 | N/A |
| 6/30/2019 | 458 | 8 | 20 | 45 | N/A |
| 3/31/2019 | 453 | 9 | 29 | 52 | N/A |
| 12/31/2018 | 453 | 14 | 33 | 50 | N/A |
| 9/30/2018 | 449 | 6 | 43 | 59 | N/A |
| 6/30/2018 | 442 | 11 | 40 | 57 | N/A |
| 3/31/2018 | 440 | 15 | N/A | 46 | N/A |
| 12/31/2017 | 434 | 7 | N/A | 39 | N/A |
| 9/30/2017 | 425 | 1 | N/A | 15 | N/A |
| 6/30/2017 | 419 | 8 | N/A | 19 | N/A |
| 3/31/2017 | 414 | -3 | N/A | 29 | N/A |
| 12/31/2016 | 410 | 3 | N/A | 59 | N/A |
| 9/30/2016 | 406 | 11 | N/A | 55 | N/A |
| 6/30/2016 | 409 | 0 | N/A | 56 | N/A |
| 3/31/2016 | 405 | 10 | N/A | 46 | N/A |
| 12/31/2015 | 396 | -2 | N/A | 44 | N/A |
| 9/30/2015 | 392 | -10 | N/A | 42 | N/A |
| 6/30/2015 | 392 | -9 | N/A | 42 | N/A |
| 3/31/2015 | 392 | -10 | N/A | 64 | N/A |
| 12/31/2014 | 402 | -4 | N/A | 51 | N/A |
| 9/30/2014 | 408 | -8 | N/A | 51 | N/A |
| 6/30/2014 | 399 | -25 | N/A | 51 | N/A |
| 3/31/2014 | 395 | -26 | N/A | 42 | N/A |
| 12/31/2013 | 398 | -18 | N/A | 67 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: OFIX is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: OFIX is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: OFIX is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: OFIX's revenue (6.2% per year) is forecast to grow slower than the US market (8.9% per year).
Hohe Wachstumseinnahmen: OFIX's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if OFIX's Return on Equity is forecast to be high in 3 years time